weight loss stopped on tirzepatide regain after the withdrawal of (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated. Read more at: https://www.medpagetoday.com/endocrinology/obesity tirzepatide weight loss stall Hitting

ITV News bought fake products via a WhatsApp account and sent them to a laboratory to be tested

Maximize your tan's longevity with post-tanning care

GLP-1 and gallbladder risk is real but modest

We believe in this ability to deliver real precision medicine to patients at scale for affordable prices, though prices have not yet been disclosed

The available evidence has prompted professional and medical societies to recommend GLP-1RAs for mitigation of the cardiovascular risk in people with type 2 diabetes

Semaglutide, Novo Nordisks blockbuster GLP-1 receptor agonist marketed as Ozempic and Wegovy, has revolutionized the management of type 2 diabetes and obesity